Mersana Therapeutics Inc.

NASDAQ: MRSN · Real-Time Price · USD
0.39
0.00 (1.06%)
At close: Jun 09, 2025, 3:59 PM

Mersana Therapeutics Revenue

Mersana Therapeutics reported an annual revenue of $40.5M, reflecting a 9.88% growth. For the quarter ending March 31, 2025, Mersana Therapeutics generated $2.75M in revenue.
Revenue (ttm)
$40.5M
Revenue Growth
9.88%
Price / Sales Ratio
4.33
Revenue / Employee
$397.03K
Employees
102
Market Cap
49.08M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.